Gossamer Bio GOSS
NASDAQ GOSS
$0.15 0.00 (-2.35%)
As of: Aug 21, 2026 · 12:29 PM EDT

Gossamer Bio (GOSS) Receivables - Other (2024 - 2026)

Gossamer Bio (GOSS) posted quarterly Receivables - Other of $100000.0 for Q1 2026, little changed year-over-year from $100000.0 in Q1 2025, and down 66.67% quarter-over-quarter from $300000.0 in Q4 2025.

Gossamer Bio (GOSS) Receivables - Other (2024 - 2026) Analysis & Trends

Gossamer Bio's Receivables - Other history runs 3 years deep, the most recent figure standing at $100000.0 for Q1 2026.

  • In Q1 2026, Receivables - Other changed 0.0% year-over-year to $100000.0; the TTM figure through Mar 2026 stood at $100000.0 (changed 0.0% YoY), while the FY2025 annual figure was $300000.0, up 50.0% from the prior year.
  • Receivables - Other for Q1 2026 stood at $100000.0, down from $300000.0 in the prior quarter.
  • The five-year high for Receivables - Other was $400000.0 in Q2 2025, with the low at $100000.0 in Q3 2024.
  • The 3-year median for Receivables - Other is $250000.0 (2024), against an average of $237500.0.
  • The sharpest annual moves came in 2025 and 2026: Receivables - Other soared 300.0% in 2025, then changed 0.0% in 2026.
  • Gossamer Bio's Receivables - Other stood at $200000.0 in 2024, then jumped by 50.0% to $300000.0 in 2025, then slumped by 66.67% to $100000.0 in 2026.
  • Business Quant data shows GOSS's Receivables - Other at $100000.0 in Q1 2026, $300000.0 in Q4 2025, and $400000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.77 Bn 131.91 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.74 Bn 78.75 Bn 3.93 Bn
3 Argenx Se 65.36 Bn 60.17 Bn 1.37 Bn
4 Moderna 59.60 Bn 54.47 Bn 52.00 Mn
5 BeOne Medicines 42.10 Bn 37.00 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.80 Bn 28.49 Bn 992.69 Mn
7 BioNTech SE 28.13 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.54 Bn 26.38 Bn 358.27 Mn
9 Royalty Pharma 27.31 Bn 26.47 Bn -
10 Gossamer Bio 49.03 Mn -8.00 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 100,000.00
Mar 31, 2026 100,000.00
Dec 31, 2025 300,000.00
Dec 31, 2025 300,000.00
Sep 30, 2025 400,000.00
Sep 30, 2025 400,000.00
Jun 30, 2025 400,000.00
Jun 30, 2025 400,000.00
Mar 31, 2025 100,000.00
Mar 31, 2025 100,000.00
Dec 31, 2024 200,000.00
Dec 31, 2024 200,000.00
Sep 30, 2024 100,000.00
Sep 30, 2024 100,000.00
Jun 30, 2024 300,000.00
Jun 30, 2024 300,000.00